Hepatitis Forums

Hepatitis C Main Forums => Hepatitis C Research News & Studies => Topic started by: Hep Editors on February 11, 2019, 10:39:21 am

Title: Epclusa Is Broadly Effective Against Hep C in Real-World Use
Post by: Hep Editors on February 11, 2019, 10:39:21 am

Gilead Sciences’ Epclusa (sofosbuvir/velpatasvir) is highly effective at curing hepatitis C virus (HCV) among a broad array of subgroups.

Presenting their findings at the Annual Meeting of the American Association for the Study of Liver Diseases in San Francisco (The Liver Meeting), researchers analyzed data from the British Columbia Hepatitis Testers Cohort. They assembled a cohort of 1,801 people with hep C who filled at least one prescription for HCV treatment with Epclusa through June 30, 2018, in routine clinical care and about whom there were at least 12 weeks of follow-up data.

For more...
https://www.hepmag.com/article/epclusa-broadly-effective-hep-c-realworld-use